{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03908",
      "entity_text" : "LDL",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:11103" ],
      "TissueType" : [ "tissuelist:TS-0923" ]
    }
  },
  "verbose_text" : "Moreover, the clearance of HCV using combination therapy with daclatasvir (DAC) and asunaprevir (ASV), an IFN-free antiviral regimen, resulted in rapid changes in serum lipid profile and disturbed lipid metabolism, whereas results reported by Jain and his colleagues showed that total cholesterol levels and LDL levels were significantly elevated after SOF / DAC treatment, which may impact the cardiovascular events associated with hepatitis C treatment [XREF_BIBR].",
  "reading_complete" : "2020-08-03T16:03:55Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T15:58:53Z",
  "trigger" : "levels",
  "evidence" : [ "LDL levels" ],
  "pmc_id" : "7380473",
  "score" : 0
}